The Scientist

» drug development and neuroscience

Most Recent

image: Do Brighter Species’ Brains Emit Redder Light?

Do Brighter Species’ Brains Emit Redder Light?

By | October 1, 2016

Photon emissions in the brain are red-shifted in more-intelligent species, though scientists dispute what that means.

0 Comments

image: Pet Meds Adapted from Human Therapies

Pet Meds Adapted from Human Therapies

By | October 1, 2016

Companies focused on developing treatments for dogs, cats, and horses are bringing a diverse array of products to the pet medicine market.

0 Comments

image: New and Old Techniques in Modern Neuroscience

New and Old Techniques in Modern Neuroscience

By | October 1, 2016

Imaging and manipulating the brain has come a long way from electrodes and the patch clamp, though such traditional tools remain essential.

0 Comments

image: Thirty Years of Progress

Thirty Years of Progress

By | October 1, 2016

Since The Scientist published its first issue in October 1986, life-science research has transformed from a manual and often tedious task to a high-tech, largely automated process of unprecedented efficiency.

1 Comment

image: Circadian-Controlled Thirst

Circadian-Controlled Thirst

By | September 28, 2016

Scientists determine how the brain’s central clock regulates drinking prior to sleep in rodents.

1 Comment

image: Q&A: From FDA to Industry

Q&A: From FDA to Industry

By | September 27, 2016

Among a subset of US Food and Drug Administration regulators who leave the agency, more than half go to work for pharmaceutical companies, researchers report.

1 Comment

image: Facebook CEO’s Donation a Boon to Basic Science

Facebook CEO’s Donation a Boon to Basic Science

By | September 25, 2016

But can $3 billion dollars meet the lofty goals of the Chan Zuckerberg Initiative?

1 Comment

image: Allergan’s Buying Spree Rolls On

Allergan’s Buying Spree Rolls On

By | September 21, 2016

The Ireland-based pharma company makes a $1.7 billion offer to acquire Tobira Therapeutics, a US firm developing liver disease drugs.

0 Comments

image: Feds Demand More Clinical Trial Reporting

Feds Demand More Clinical Trial Reporting

By | September 19, 2016

Expanded US Health and Human Services rules will require the results of more human studies to be made public.

1 Comment

image: Allergan Set to Buy Vitae

Allergan Set to Buy Vitae

By | September 16, 2016

The Irish drugmaker has made a $639 million dollar offer to buy the US-based biopharma.

0 Comments

Popular Now

  1. Broad Wins CRISPR Patent Interference Case
    Daily News Broad Wins CRISPR Patent Interference Case

    The USPTO’s Patent Trial and Appeal Board has ruled in favor of the Broad Institute of MIT and Harvard retaining intellectual property rights covered by its patents for CRISPR gene-editing technology.

  2. Henrietta Lacks’s Family Seeks Compensation
  3. Can Plants Learn to Associate Stimuli with Reward?
  4. Humans Never Stopped Evolving
    Features Humans Never Stopped Evolving

    The emergence of blood abnormalities, an adult ability to digest milk, and changes in our physical appearance point to the continued evolution of the human race.

Business Birmingham